PaxView® SARS-CoV-2 MPCR-ULFA Kit is for the qualitative detection of SARS-CoV-2 viral RNA in oropharyngeal swab, nasopharyngeal swab, sputum and bronchoalveolar lavage (BAL). 

The PaxView® SARS-CoV-2 MPCR-ULFA Kit detects the novel coronavirus, SARS-CoV-2 by using one-step RT-PCR in a single tube and ULFA array detection system. The target genes for the detection of the virus are Orf1ab and N gene. The kit includes primers set targeting the human RNase P gene that serves as an internal positive control for the multiplex PCR. 

[Domestic/International Authorization and Patent]

MFDS approval, CE-IVD

Patent: 10-1727111, 10-1795773, US 10,640,821 B2

[Features and Advantages]

Application of MPCR-ULFA (Multiplex PCR-Universal Lateral Flow Assay) platform technology, a proprietary patented technology

The target genes Orf1ab(RdRp) and N gene

Limit of detection(LoD) is 10 copies/µl (50 copies/reaction)

One-step RT-PCR in a single tube

Monitor the entire process including the sample collection, RNA extraction, and RT-PCR through using internal control, Human Rnase P gene

Prevention of PCR carry-over contamination using UDG system

All PCR equipment can be used

User-friendly & Simple method

Visual check of results within 10~15 minutes, Easy to use